Cancer Channel
Topics
Medications
Quicklinks
Related Channels

CML and Dasatinib

A healthcare provider may prescribe dasatinib (Sprycel®) to help treat a certain type of leukemia called chronic myeloid leukemia (CML). This medication is approved for use in adults age 18 and older.
 
CML is a slowly progressing leukemia in which bone marrow stem cells (the early cells that form blood cells) develop into many abnormal granulocytes (a type of white blood cell). Some of these cells never become mature white blood cells (also called blasts). Over time, the granulocytes and blasts crowd out the red blood cells and platelets in the bone marrow.
 
Dasatinib works to treat CML by reducing the activity of a certain type of protein in the body that the cancer cells need to grow.
 
(Click What Is Dasatinib Used For? for more information, including how dasatinib is used for treating other types of leukemia. This article also covers some unapproved uses for this chemotherapy medication.)
The Zen of Cancer Caregiving - Recharge Your Batteries!
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.